Pharma Mar SAU
Save
1.42B
Market cap
2026.75x
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Pharma Mar, S. A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference.
Similar securities
Based on sector and market capitalization
Report issue